Other important inflammation regulators that were upregulated in RA (Figures 3C–I) included CFS-1 (also known as M-CFS) (34) and CD40 that have been suggested as therapeutic targets in RA (35). This evidence concerns the gene CD40 and rheumatoid arthritis.